Results 1 to 10 of about 21,635 (251)

Estudo comparativo entre a síndrome antifosfolípide primária e a secundária: características clínico-laboratoriais em 149 pacientes Comparative study between primary and secondary antiphospholipid syndrome: clinic and laboratorial characteristics of 149 patients [PDF]

open access: yesRevista Brasileira de Reumatologia, 2008
OBJETIVOS: O presente estudo tem como objetivo analisar as características clínicas, laboratoriais e imunológicas dos pacientes com síndrome antifosfolípide (SAF) e comparar indivíduos portadores da síndrome primária com portadores da secundária ...
Caio Robledo D'Angioli Costa Quaio   +2 more
doaj   +4 more sources

Storage in ultra-low-temperature decreases the levels of IgM anticardiolipin antibody in serum samples from tuberculosis patients [PDF]

open access: bronzeTherapeutic Advances in Respiratory Disease, 2014
The evaluation of novel tuberculosis (TB) biomarkers relies on analysis of previously stored sample sets. We aimed to determine the effect of storage temperature on serum IgM anticardiolipin antibody levels in samples from TB patients.
Alexandra Ng   +2 more
doaj   +2 more sources

The absence of standardization in antiphospholipid antibody testing may favor the use of 99th percentile cutoffs in antiphospholipid syndrome classification [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Classification criteria for antiphospholipid syndrome (APS) issued by the American College of Rheumatology/European Alliance of Associations for Rhuematology necessitate a positivity for any of the 3 molecular targets: lupus anticoagulant ...
Ariadna Anunciación-Llunell   +7 more
doaj   +2 more sources

Advances in the Research on Anticardiolipin Antibody [PDF]

open access: goldJournal of Immunology Research, 2019
Anticardiolipin antibody (ACA) is a kind of autoantibody and is one of the antiphospholipid antibodies (aPLs). Phospholipids with a negative charge on platelets and endothelial cell membranes are ACA target antigens.
Dan Wang   +3 more
doaj   +2 more sources

Extensive Pulmonary Embolism in late pregnancy associated with Anticardiolipin Antibodies [PDF]

open access: green, 2004
The leading cause of morbidity and mortality during pregnancy and the puerperium is venous thromboembolism. Though uncommon, the risk is five times higher in a pregnant woman than in a non-pregnant woman of similar age.1,2 In pregnancy, all three ...
Brincat, Mark P.   +5 more
core   +2 more sources

Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks

open access: yesInternational Journal of Preventive Medicine, 2023
Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19.
Somayeh Haghighipour   +5 more
doaj   +1 more source

Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes

open access: yesFrontiers in Immunology, 2022
ObjectiveThe purpose of the study is to evaluate the effects of anticardiolipin (aCL) and/or anti-β2-glycoprotein-I (aβ2GPI) antibodies, namely antiphospholipid antibodies (aPL), on in vitro fertilization (IVF) outcomes.Materials and methodsThe study ...
Li Wu   +6 more
doaj   +1 more source

Evaluation of Serum Anticardiolipin Antibodies and D-dimer in Recipients of COVID-19 Vaccines in Ado-Ekiti, Ekiti State, Nigeria

open access: yesJournal of Applied Sciences and Environmental Management, 2023
Coronavirus disease 2019 (COVID-19) manifests itself in a variety of ways, implying a wide range of host autoimmune responses which could lead to disseminated intravascular coagulation.
O. O. Odewusi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy